AB50452
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
5mg | 95% | in stock | $34.00 | $24.00 | - + | |
25mg | 95% | in stock | $90.00 | $63.00 | - + | |
100mg | 95% | in stock | $169.00 | $118.00 | - + | |
250mg | 95% | in stock | $289.00 | $203.00 | - + | |
1g | 95% | in stock | $750.00 | $525.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AB50452 |
Chemical Name: | N-(Cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]benzamide |
CAS Number: | 1056634-68-4 |
Molecular Formula: | C23H22N6O2 |
Molecular Weight: | 414.4598 |
MDL Number: | MFCD16038899 |
SMILES: | N#CCNC(=O)c1ccc(cc1)c1ccnc(n1)Nc1ccc(cc1)N1CCOCC1 |
Complexity: | 615 |
Covalently-Bonded Unit Count: | 1 |
Heavy Atom Count: | 31 |
Hydrogen Bond Acceptor Count: | 7 |
Hydrogen Bond Donor Count: | 2 |
Rotatable Bond Count: | 6 |
XLogP3: | 2.6 |
N-(Cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]benzamide is a valuable reagent in chemical synthesis due to its unique structure and versatile functional groups. This compound is commonly used as a key building block for the synthesis of complex organic molecules and pharmaceutical intermediates.Its cyanomethyl group serves as an excellent electrophile, allowing for efficient and selective reactions with nucleophiles in synthetic pathways. The presence of the pyrimidine and benzamide moieties enhances the molecule's reactivity and compatibility with a variety of reaction conditions.In addition, the morpholinyl and phenylamino groups provide opportunities for further diversification through functional group transformations and derivatization. This flexibility makes N-(Cyanomethyl)-4-[2-[[4-(4-morpholinyl)phenyl]amino]-4-pyrimidinyl]benzamide a valuable tool for the synthesis of structurally diverse compounds with potential applications in medicinal chemistry, materials science, and other areas of research and development.
Blood cancer journal 20180301
The Lancet. Haematology 20180201
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 20160801
Bioorganic & medicinal chemistry letters 20130801
Molecular diagnosis & therapy 20121001
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120501
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 20120501
Hematology (Amsterdam, Netherlands) 20120401
Current opinion in hematology 20120301
Nature biotechnology 20120109
Leukemia 20111201
Current opinion in hematology 20110301
Blood 20100624
Bioorganic & medicinal chemistry letters 20091015
Leukemia 20090801